-+ 0.00%
-+ 0.00%
-+ 0.00%

CASTLE BIOSCIENCES INC - SCIBASE TO DEFER CLINICAL DEVELOPMENT COSTS FOR INITIAL INDICATION

Reuters·06/16/2025 20:30:00

Please log in to view news